To evaluate the comedogenic effect of skincare formulation Cebhydra Lotion on healthy human female subjects

Sun Pharmaceutical Industries Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月2日

试验速览

暂无简介。

•1)Indian female subjects
•2)Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
•3)Between 18 and 35 years of age.
•4)Skin is healthy on the studied anatomic unit (e.g. free of eczema, wounds, inflammatory scar)
•5)Having oily or mixed oily skin type on the face. (Visual assessment by dermatologist)

•1)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
•2)Having refused to give her assent by not signing the consent form
•3)Taking part in another study liable to interfere with this study
•4)In the previous 6 months
•-Having started, changed or stopped a hormonal treatment (e.g. hormonal contraception, cyproterone acetate)
•-Having taken an oral retinoid-based treatment
•-Having undergone a physical (e.g., phototherapy, laser) or chemical (peeling) treatment for acne
•5)In the previous 1 month
•-Having had a local benzoyl-peroxide-based treatment or a local retinoid-based treatment
•-Having had an oral treatment with a base of cimetidine, zinc (zinc gluconate) or spironolactone
•6)In the previous 2 weeks
•-Having applied cosmetic products with anti-seborrheic aims or cosmetics for oily skin
•-Having had oral or local antibiotic treatment for acne
•7)In the previous 1 week
•-Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask)
•-Having a suntanned skin on the studied areas which could interfere with the evaluations of the study

发起方